phosphorylcholine has been researched along with gemcitabine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, MR; Georgieva, MC; Konstantinov, SM; Topashka-Ancheva, M | 1 |
| Chen, B; Cheng, L; Hong, DF; Shen, XD; Xin, Y | 1 |
| Câmara, AS; Faria, RC; Materon, EM; Nascimento, GF; Oliveira, ON; Sandrino, B; Shimizu, FM | 1 |
3 other study(ies) available for phosphorylcholine and gemcitabine
| Article | Year |
|---|---|
Combination effects of alkylphosphocholines and gemcitabine in malignant and normal hematopoietic cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Cell Survival; Cell-Free System; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Gemcitabine; Hematopoietic Stem Cells; HL-60 Cells; Humans; K562 Cells; Phosphorylcholine; Reference Values; Tumor Cells, Cultured | 2002 |
Perifosine inhibits S6K1-Gli1 signaling and enhances gemcitabine-induced anti-pancreatic cancer efficiency.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Deoxycytidine; Disease Progression; Dose-Response Relationship, Drug; Drug Synergism; Gemcitabine; Gene Knockdown Techniques; Humans; Male; Mice; Mice, SCID; Pancreatic Neoplasms; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Random Allocation; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Small Interfering; Signal Transduction; Survival Analysis; Transcription Factors; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1 | 2014 |
Role of sphingomyelin on the interaction of the anticancer drug gemcitabine hydrochloride with cell membrane models.
Topics: Antineoplastic Agents; Cell Membrane; Deoxycytidine; Gemcitabine; Glycerol; Phosphorylcholine; Sphingomyelins | 2020 |